Skip to content

Postdischarge nutrition in infants born

Postdischarge nutrition in infants born <32 weeks gestation and/or <1500 grams birth weight: relation with growth, body composition, and metabolic health at 7 years.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29242
Enrollment
100
Registered
2011-07-06
Start date
2011-03-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth

Interventions

Subjects will follow a regular diet for seven days followed by evaluation of blood pressure at our outpatient clinic. Several weeks later they use a regular diet enriched with 0,12 gram/kg/day salt (h

Sponsors

VU University Medical Center Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of the “Study Towards the Effect of Postdischarge nutrition on growth and body composition in infants born <32 weeks gestational age and/or <1500 gram birth weight” at 7 years of age.

Exclusion criteria

Exclusion criteria: Subjects with the following criteria will be excluded from the study: 1. Gastro-intestinal surgery and disease known to influence growth (i.e. cystic fibrosis); 2. Known presence of growth hormone, IGF-1, or other pituitary hormone deficiencies; 3. Concurrent therapies with substances known or suspected to be associated with alteration of growth; 4. Cardiac, renal, pulmonary, and liver disease; 5. Chromosomal and/or genetic syndromes (other than Silver-Russel); 6. Known presence of skeletal disease; 7. Severe illness.

Design outcomes

Primary

MeasureTime frame
1. Anthropometry; 2. Body composition (lean mass, fat mass).

Secondary

MeasureTime frame
1. Blood pressure; 2. Endocrine parameters (e.g. insulin, glucose, IGF-1, FT4, TSH, cortisol); 3. Salt sensitivity of blood pressure; 4. Lipid status; 5. Neuromotor and cognitive development; 6. Bone mineralization.

Contacts

Public ContactM. Lagemaat, van de

VU University Medical Center De Boelelaan 1117

m.vandelagemaat@vumc.nl+31 (0)20 4443137

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)